Prospective Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 323-331
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.323
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flow diagram of phase I and phase II included and excluded participants. HCV: Hepatitis C virus; HBsAg: Hepatitis B surface antigen.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 The incidence of fatal and non-fatal cardiovascular disease events in individuals with and without non-alcholic fatty liver disease during a 7-yr follow up in men and women. CVD: Cardiovascular disease; WW: Women Without non-alcholic fatty liver disease; MN: Men with non-alcholic fatty liver disease; significant P value showed by score.
  • Citation: Motamed N, Ajdarkosh H, Ahmadi M, Perumal D, Ashrafi GH, Nikkhah M, Faraji AH, Maadi M, Khoonsari M, Rezaie N, Farahani B, Safarnezhad Tameshkel F, Ameli M, Panahi M, Karbalaie Niya MH, Zamani F. Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. World J Hepatol 2020; 12(6): 323-331
  • URL: https://www.wjgnet.com/1948-5182/full/v12/i6/323.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v12.i6.323